HIDRADENITIS SUPPURATIVA
Clinical trials for HIDRADENITIS SUPPURATIVA explained in plain language.
Never miss a new study
Get alerted when new HIDRADENITIS SUPPURATIVA trials appear
Sign up with your email to follow new studies for HIDRADENITIS SUPPURATIVA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for painful skin condition: brensocatib enters phase 2b trial
Disease control TerminatedThis study tests whether brensocatib can reduce painful lumps and abscesses in people with moderate to severe hidradenitis suppurativa (HS). About 214 adults will receive either brensocatib or a placebo for 16 weeks. The goal is to see if the drug improves skin lesions and overal…
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE2 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Experimental pill shows early promise for painful skin condition
Disease control TerminatedThis pilot study tested the drug deucravacitinib against a placebo in people with moderate-to-severe hidradenitis suppurativa, a chronic skin condition causing painful lumps. Only 7 people enrolled before the study was stopped early. The goal was to see if the drug could reduce i…
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Promising cream for painful skin condition tested in tiny trial
Disease control TerminatedThis small, early trial tested a cream called ruxolitinib 1.5% on 6 people with early-stage hidradenitis suppurativa, a painful skin condition that causes lumps and abscesses. The goal was to see if the cream could reduce inflammation and improve symptoms after 16 weeks. However,…
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pill for chronic hives and skin disease tested – but study halted early
Disease control TerminatedThis study tested an oral drug called INF904 in people with moderate to severe chronic spontaneous urticaria (long-term hives) or hidradenitis suppurativa (a painful skin condition). The trial was open-label and lasted 28 days of treatment plus follow-up. It aimed to check safety…
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE2 • Sponsor: InflaRx GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for painful skin condition: experimental drug shows promise
Disease control TerminatedThis study tested a new drug called amlitelimab for adults with moderate to severe hidradenitis suppurativa, a painful skin condition that causes boils and tunnels. About 90 people received either the drug or a placebo for 16 weeks, with an optional long-term extension. The goal …
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug trial for painful skin condition halted early
Disease control TerminatedThis study tested a drug called izokibep for people with moderate to severe hidradenitis suppurativa, a chronic skin condition causing painful lumps. The trial aimed to see if izokibep could reduce skin abscesses and inflammation. It included 258 adults who had not responded to o…
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE3 • Sponsor: ACELYRIN Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New hope for painful skin condition? study cut short
Symptom relief TerminatedThis study tested a new drug, SAR444656, in 70 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition causing boils and abscesses. Participants took the drug or a placebo for 16 weeks to see if it reduced the number of inflamed nodules and abscesse…
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE2 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New radiofrequency skin treatment studied for safety
Knowledge-focused TerminatedThis study tested a radiofrequency-based treatment on the skin of healthy volunteers and people with hidradenitis suppurativa (a painful skin condition). The main goal was to see if the treatment is safe and tolerable. The study was stopped early, but it aimed to understand how t…
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Scientists hunt for hidden family genes behind painful skin disease
Knowledge-focused TerminatedThis study aimed to find a genetic link or family trait that connects people with Hidradenitis Suppurativa (HS), a painful skin condition. Researchers collected blood or saliva samples from 97 participants, including affected individuals and their family members, to analyze DNA f…
Matched conditions: HIDRADENITIS SUPPURATIVA
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC